Promisia Healthcare Limited Ordinary Shares
PHL.NZXHealth Care
Promisia Healthcare Ltd is a public company listed on the NZX. It was formed in August 1983 as Genestock NZ Ltd. and has remained as a listed company undertaking a number of diverse activities over the last 30 years. The company came under the control of the current major shareholders and directors in 2003/4 and for some years remained a listed shell company, i.e. the company remained listed on the NZX but it did not have any substantive trading activity. For a period of time the company researched and marketed a dietary supplement called Arthrem and then in October 2020 moved in to the current aged residential care business. The business's principal activity is the provision of rest home and hospital level care. In addition, care is offered for dementia, respite, palliative and for younger people with lifelong disabilities (YPD). Promisia Healthcare Ltd currently owns and operates four aged care facilities comprising of 404 care beds. In addition, Promisia operates two retirement villages comprising of sixteen villas. There are also a further 28 villas and 10 care suites in an advanced stage of construction.
Market Data
$0.660
+0.1%$34.9M
2.7x
$0.245
0.00%
+0.9%
Latest Earnings
PHL delivers strong FY26 result and sets dividend policy
28 May 2026
Promisia Healthcare (NZX: PHL) delivered a strong FY26 result for the year ended 31 March 2026, with operating revenue up 29% to $40.1M and Underlying EBITDAF (earnings before interest, tax, depreciation, amortisation and fair value adjustments) up 58% to $6.6M, driven by higher occupancy (87% to 94%), a full year of Cromwell operations, and deferred management fee growth. NPAT from continuing operations rose 97% to $12.9M, supported by $11.7M in fair value property gains, while net operating cash flows surged 87% to $6.4M. Looking ahead, PHL guided FY27 Underlying EBITDAF of at least $8.0M (>20% growth) and introduced a dividend policy of 20–40% of Operating Free Cash Flow, while also pursuing an earnings-accretive acquisition. Key points: Underlying EBITDAF (a non-GAAP measure excluding fair value movements and non-recurring items) rose 58% to $6.6M, up 76% over two years, reflecting strong operational leverage.; Group care occupancy improved materially from 87% to 94%, a key driver of revenue and earnings growth, with FY27 target of at least 95%.; Portfolio aggregate market valuation increased 17.1% to $107.2M with all five sites increasing in value by at least 10%, lifting NTA per share 38% to $1.09 (more than doubling from $0.46 in March 2023).
Recent Announcements
PHL delivers strong FY26 result and sets dividend policy
Promisia Healthcare (NZX: PHL) delivered a strong FY26 result for the year ended 31 March 2026, with operating revenue up 29% to $40.1M and Underlying EBITDAF (earnings before interest, tax, depreciation, amortisation and fair value adjustments) up 58% to $6.6M, driven by higher occupancy (87% to 94%), a full year of Cromwell operations, and deferred management fee growth. NPAT from continuing operations rose 97% to $12.9M, supported by $11.7M in fair value property gains, while net operating cash flows surged 87% to $6.4M. Looking ahead, PHL guided FY27 Underlying EBITDAF of at least $8.0M (>20% growth) and introduced a dividend policy of 20–40% of Operating Free Cash Flow, while also pursuing an earnings-accretive acquisition. Key points: Underlying EBITDAF (a non-GAAP measure excluding fair value movements and non-recurring items) rose 58% to $6.6M, up 76% over two years, reflecting strong operational leverage.; Group care occupancy improved materially from 87% to 94%, a key driver of revenue and earnings growth, with FY27 target of at least 95%.; Portfolio aggregate market valuation increased 17.1% to $107.2M with all five sites increasing in value by at least 10%, lifting NTA per share 38% to $1.09 (more than doubling from $0.46 in March 2023).
Promisia Healthcare Valuations Increase 17%
Promisia Healthcare Limited's care facility and retirement village portfolio valuation increased 17.1% to $107.20 million as at 31 March 2026, driven by improved occupancy (87% to 94%), successful conversions and operational improvements across all five sites.
Capital Change Notice
Promisia Healthcare Limited (PHL) issued 50,000 ordinary shares on 22 April 2026 upon conversion of restricted share units (RSUs) under its Senior Executive Restricted Share Plan, with Chief Financial Officer Francisco Rodriguez Ferrere acquiring 50,000 shares (bringing his total holding to 146,600 shares) as non-cash consideration for services rendered at a conversion price of $0.4663 per share.
Capital Change Notice
Promisia Healthcare Limited (NZX: PHL) issued 25,000 ordinary shares to an employee as recognition for over-performance, representing 0.047% of the total class and fully paid at nil consideration.
Operational Update – Q4 FY26
Promisia Healthcare (NZX: PHL) reported strong operational performance in Q4 FY26, with group-wide care occupancy reaching 94% in March 2026 (up from 92% in December), driven by significant gains at Nelson Street (96%, up from 82%) and near-completion of the Ranfurly Manor care suite sales program (96% occupied, up from 51% a year prior). The company reaffirmed its FY26 earnings guidance of $6.4-6.8 million EBITDAF and announced a planned solar installation at two facilities with expected 5-6 year payback periods.
Governance Update
Promisia Healthcare Limited (NZX: PHL) announces governance changes effective from its 2026 annual shareholders meeting: Tom Brankin will step down from his executive role to become a non-executive director, with senior executives assuming his acquisition and development responsibilities, while Craig Percy will return to independent director status from 31 May 2026 after completing his temporary executive role.
FY26 Earnings Guidance Upgrade
Promisia Healthcare has upgraded its FY26 earnings guidance, now expecting underlying EBITDAF of $6.4-6.8 million (up from at least $6.1 million), representing 52-62% growth year-on-year. The upgrade reflects strong operational performance with care occupancy rates reaching ~94% across the group, including Ranfurly Manor at ~95% and Nelson Street above 92%. Key points: Earnings guidance upgraded to $6.4-6.8M EBITDAF, representing 52-62% year-on-year growth; Strong occupancy rates across portfolio with group care occupancy at ~94%; Ranfurly Manor care suite occupancy reached ~95%
Get real-time alerts for PHL
Receive AI-powered earnings summaries and instant notifications when Promisia Healthcare Limited Ordinary Shares releases results.
Register Free